ClinicalTrials.govpublic full text
Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension
ovarian cancer, antiangiogenic-associated hypertension, adjuvant bevacizumab, hypertension
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 668861
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.